Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression

The progression of chronic obstructive pulmonary disease (COPD) is associated with marked alterations in circulating immune cell populations, but no studies have characterized alterations in these cell types across the full spectrum of lung function impairment in current and former smokers. In 6,299...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory cell and molecular biology Vol. 58; no. 4; pp. 500 - 509
Main Authors Halper-Stromberg, Eitan, Yun, Jeong H., Parker, Margaret M., Singer, Ruth Tal, Gaggar, Amit, Silverman, Edwin K., Leach, Sonia, Bowler, Russell P., Castaldi, Peter J.
Format Journal Article
LanguageEnglish
Published United States American Thoracic Society 01.04.2018
Subjects
Online AccessGet full text
ISSN1044-1549
1535-4989
1535-4989
DOI10.1165/rcmb.2017-0373OC

Cover

Abstract The progression of chronic obstructive pulmonary disease (COPD) is associated with marked alterations in circulating immune cell populations, but no studies have characterized alterations in these cell types across the full spectrum of lung function impairment in current and former smokers. In 6,299 subjects from the COPDGene and ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints) studies, we related Coulter blood counts and proportions to cross-sectional forced expiratory volume in 1 second (FEV ), adjusting for current smoking status. We also related cell count measures to 3-year change in FEV in ECLIPSE subjects. In a subset of subjects with blood gene expression data, we used cell type deconvolution methods to infer the proportions of immune cell subpopulations, and we related these to COPD clinical status. We observed that FEV levels are positively correlated with lymphocytes and negatively correlated with myeloid populations, such as neutrophils and monocytes. In multivariate models, absolute cell counts and proportions were associated with cross-sectional FEV , and lymphocytes, monocytes, and eosinophil counts were predictive of 3-year change in lung function. Using cell type deconvolution to study immune cell subpopulations, we observed that subjects with COPD had a lower proportion of CD4 resting memory cells and naive B cells compared with smokers without COPD. Alterations in circulating immune cells in COPD support a mixed pattern of lymphocyte suppression and an enhanced myeloid cell immune response. Cell counts and proportions contribute independent information to models predicting lung function, suggesting a critical role for immune response in long-term COPD outcomes. Cell type deconvolution is a promising method for immunophenotyping in large cohorts.
AbstractList The progression of chronic obstructive pulmonary disease (COPD) is associated with marked alterations in circulating immune cell populations, but no studies have characterized alterations in these cell types across the full spectrum of lung function impairment in current and former smokers. In 6,299 subjects from the COPDGene and ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints) studies, we related Coulter blood counts and proportions to cross-sectional forced expiratory volume in 1 second (FEV1), adjusting for current smoking status. We also related cell count measures to 3-year change in FEV1 in ECLIPSE subjects. In a subset of subjects with blood gene expression data, we used cell type deconvolution methods to infer the proportions of immune cell subpopulations, and we related these to COPD clinical status. We observed that FEV1 levels are positively correlated with lymphocytes and negatively correlated with myeloid populations, such as neutrophils and monocytes. In multivariate models, absolute cell counts and proportions were associated with cross-sectional FEV1, and lymphocytes, monocytes, and eosinophil counts were predictive of 3-year change in lung function. Using cell type deconvolution to study immune cell subpopulations, we observed that subjects with COPD had a lower proportion of CD4+ resting memory cells and naive B cells compared with smokers without COPD. Alterations in circulating immune cells in COPD support a mixed pattern of lymphocyte suppression and an enhanced myeloid cell immune response. Cell counts and proportions contribute independent information to models predicting lung function, suggesting a critical role for immune response in long-term COPD outcomes. Cell type deconvolution is a promising method for immunophenotyping in large cohorts.The progression of chronic obstructive pulmonary disease (COPD) is associated with marked alterations in circulating immune cell populations, but no studies have characterized alterations in these cell types across the full spectrum of lung function impairment in current and former smokers. In 6,299 subjects from the COPDGene and ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints) studies, we related Coulter blood counts and proportions to cross-sectional forced expiratory volume in 1 second (FEV1), adjusting for current smoking status. We also related cell count measures to 3-year change in FEV1 in ECLIPSE subjects. In a subset of subjects with blood gene expression data, we used cell type deconvolution methods to infer the proportions of immune cell subpopulations, and we related these to COPD clinical status. We observed that FEV1 levels are positively correlated with lymphocytes and negatively correlated with myeloid populations, such as neutrophils and monocytes. In multivariate models, absolute cell counts and proportions were associated with cross-sectional FEV1, and lymphocytes, monocytes, and eosinophil counts were predictive of 3-year change in lung function. Using cell type deconvolution to study immune cell subpopulations, we observed that subjects with COPD had a lower proportion of CD4+ resting memory cells and naive B cells compared with smokers without COPD. Alterations in circulating immune cells in COPD support a mixed pattern of lymphocyte suppression and an enhanced myeloid cell immune response. Cell counts and proportions contribute independent information to models predicting lung function, suggesting a critical role for immune response in long-term COPD outcomes. Cell type deconvolution is a promising method for immunophenotyping in large cohorts.
The progression of chronic obstructive pulmonary disease (COPD) is associated with marked alterations in circulating immune cell populations, but no studies have characterized alterations in these cell types across the full spectrum of lung function impairment in current and former smokers. In 6,299 subjects from the COPDGene and ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints) studies, we related Coulter blood counts and proportions to cross-sectional forced expiratory volume in 1 second (FEV ), adjusting for current smoking status. We also related cell count measures to 3-year change in FEV in ECLIPSE subjects. In a subset of subjects with blood gene expression data, we used cell type deconvolution methods to infer the proportions of immune cell subpopulations, and we related these to COPD clinical status. We observed that FEV levels are positively correlated with lymphocytes and negatively correlated with myeloid populations, such as neutrophils and monocytes. In multivariate models, absolute cell counts and proportions were associated with cross-sectional FEV , and lymphocytes, monocytes, and eosinophil counts were predictive of 3-year change in lung function. Using cell type deconvolution to study immune cell subpopulations, we observed that subjects with COPD had a lower proportion of CD4 resting memory cells and naive B cells compared with smokers without COPD. Alterations in circulating immune cells in COPD support a mixed pattern of lymphocyte suppression and an enhanced myeloid cell immune response. Cell counts and proportions contribute independent information to models predicting lung function, suggesting a critical role for immune response in long-term COPD outcomes. Cell type deconvolution is a promising method for immunophenotyping in large cohorts.
The progression of chronic obstructive pulmonary disease (COPD) is associated with marked alterations in circulating immune cell populations, but no studies have characterized alterations in these cell types across the full spectrum of lung function impairment in current and former smokers. In 6,299 subjects from the COPDGene and ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints) studies, we related Coulter blood counts and proportions to cross-sectional forced expiratory volume in 1 second (FEV1), adjusting for current smoking status. We also related cell count measures to 3-year change in FEV1 in ECLIPSE subjects. In a subset of subjects with blood gene expression data, we used cell type deconvolution methods to infer the proportions of immune cell subpopulations, and we related these to COPD clinical status. We observed that FEV1 levels are positively correlated with lymphocytes and negatively correlated with myeloid populations, such as neutrophils and monocytes. In multivariate models, absolute cell counts and proportions were associated with cross-sectional FEV1, and lymphocytes, monocytes, and eosinophil counts were predictive of 3-year change in lung function. Using cell type deconvolution to study immune cell subpopulations, we observed that subjects with COPD had a lower proportion of CD41 resting memory cells and naive B cells compared with smokers without COPD. Alterations in circulating immune cells in COPD support a mixed pattern of lymphocyte suppression and an enhanced myeloid cell immune response. Cell counts and proportions contribute independent information to models predicting lung function, suggesting a critical role for immune response in long-term COPD outcomes. Cell type deconvolution is a promising method for immunophenotyping in large cohorts.
The progression of chronic obstructive pulmonary disease (COPD) is associated with marked alterations in circulating immune cell populations, but no studies have characterized alterations in these cell types across the full spectrum of lung function impairment in current and former smokers. In 6,299 subjects from the COPDGene and ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints) studies, we related Coulter blood counts and proportions to cross-sectional forced expiratory volume in 1 second (FEV1), adjusting for current smoking status. We also related cell count measures to 3-year change in FEV1 in ECLIPSE subjects. In a subset of subjects with blood gene expression data, we used cell type deconvolution methods to infer the proportions of immune cell subpopulations, and we related these to COPD clinical status. We observed that FEV1 levels are positively correlated with lymphocytes and negatively correlated with myeloid populations, such as neutrophils and monocytes. In multivariate models, absolute cell counts and proportions were associated with cross-sectional FEV1, and lymphocytes, monocytes, and eosinophil counts were predictive of 3-year change in lung function. Using cell type deconvolution to study immune cell subpopulations, we observed that subjects with COPD had a lower proportion of CD4+ resting memory cells and naive B cells compared with smokers without COPD. Alterations in circulating immune cells in COPD support a mixed pattern of lymphocyte suppression and an enhanced myeloid cell immune response. Cell counts and proportions contribute independent information to models predicting lung function, suggesting a critical role for immune response in long-term COPD outcomes. Cell type deconvolution is a promising method for immunophenotyping in large cohorts.
Author Silverman, Edwin K.
Halper-Stromberg, Eitan
Parker, Margaret M.
Leach, Sonia
Gaggar, Amit
Bowler, Russell P.
Singer, Ruth Tal
Yun, Jeong H.
Castaldi, Peter J.
Author_xml – sequence: 1
  givenname: Eitan
  surname: Halper-Stromberg
  fullname: Halper-Stromberg, Eitan
  organization: University of Colorado School of Medicine, Aurora, Colorado, National Jewish Health, Denver, Colorado
– sequence: 2
  givenname: Jeong H.
  surname: Yun
  fullname: Yun, Jeong H.
  organization: Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
– sequence: 3
  givenname: Margaret M.
  surname: Parker
  fullname: Parker, Margaret M.
  organization: Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
– sequence: 4
  givenname: Ruth Tal
  surname: Singer
  fullname: Singer, Ruth Tal
  organization: GSK, King of Prussia, Pennsylvania
– sequence: 5
  givenname: Amit
  surname: Gaggar
  fullname: Gaggar, Amit
  organization: Division of Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; and
– sequence: 6
  givenname: Edwin K.
  surname: Silverman
  fullname: Silverman, Edwin K.
  organization: Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
– sequence: 7
  givenname: Sonia
  surname: Leach
  fullname: Leach, Sonia
  organization: National Jewish Health, Denver, Colorado
– sequence: 8
  givenname: Russell P.
  surname: Bowler
  fullname: Bowler, Russell P.
  organization: University of Colorado School of Medicine, Aurora, Colorado, National Jewish Health, Denver, Colorado
– sequence: 9
  givenname: Peter J.
  surname: Castaldi
  fullname: Castaldi, Peter J.
  organization: Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Boston, Massachusetts
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29206476$$D View this record in MEDLINE/PubMed
BookMark eNp1kk9vFCEYxompsX_07smQePEyFRiGGS4mm1XrJm22yeqZMMy7XeoMrMCs2U_i1y3jto026QkCv-fJ-8Bzio6cd4DQW0rOKRXVx2CG9pwRWhekrMvl_AU6oVVZFVw28ijvCecFrbg8Rqcx3hJCWUPpK3TMJCOC1-IE_VntY4LBGnylw08IEfs1nnV6m-wOsHYdXjinE-DFMIzOpj2eBcCzGL2x-bjDv23a4PkmeJc9lm1MYTR_tddjP3inwx5_thF0BLyCHYTJYrJdbW3wA6SQZQ_AdfA3AWK03r1GL9e6j_Dmfj1DP75--T7_VlwuLxbz2WVhSspSYbTRFdWE1JS2LatNu26YkUZy0UjBW2hExaEEKBvWdAxqU1HDeZfTS2E6Xp6hTwff7dgO0BlwKehebYMd8ujKa6v-v3F2o278TlWN5BWh2eDDvUHwv0aISQ02Guh77cCPUVFZl7wSUkzo-yforR-Dy_EUIzmOEISITL37d6LHUR7-LAPkAJjgYwywfkQoUVMt1FQLNdVCHWqRJeKJxNikU37nnMn2zwvvAGRiwN0
CitedBy_id crossref_primary_10_1016_j_celrep_2023_112525
crossref_primary_10_1038_s41598_022_25520_8
crossref_primary_10_2147_COPD_S316304
crossref_primary_10_2147_COPD_S347607
crossref_primary_10_1186_s12931_022_02013_w
crossref_primary_10_26693_jmbs05_03_068
crossref_primary_10_3389_fnut_2024_1421450
crossref_primary_10_1016_j_lfs_2020_118357
crossref_primary_10_2147_COPD_S369161
crossref_primary_10_3389_fimmu_2023_1134123
crossref_primary_10_1016_j_compbiomed_2023_107685
crossref_primary_10_1183_13993003_03927_2020
crossref_primary_10_1172_jci_insight_152186
crossref_primary_10_1093_annonc_mdy326
crossref_primary_10_1164_rccm_202306_0978ED
crossref_primary_10_1016_j_rmed_2023_107421
crossref_primary_10_1183_13993003_04590_2020
crossref_primary_10_1165_rcmb_2018_0245PS
crossref_primary_10_1186_s12931_019_1105_z
crossref_primary_10_2147_COPD_S268955
crossref_primary_10_1080_02770903_2022_2043361
crossref_primary_10_1159_000515180
crossref_primary_10_1183_16000617_0055_2024
crossref_primary_10_1186_s12951_023_01911_5
crossref_primary_10_3389_fimmu_2023_1297577
crossref_primary_10_1080_03009742_2020_1843705
crossref_primary_10_1080_17476348_2023_2205127
crossref_primary_10_1183_23120541_00288_2019
crossref_primary_10_1016_j_angen_2023_200159
crossref_primary_10_1016_j_toxlet_2021_05_010
Cites_doi 10.1016/j.ygeno.2016.01.004
10.1164/ajrccm.152.3.7663792
10.1145/1961189.1961199
10.1164/rccm.201701-0218PP
10.4049/jimmunol.0802622
10.1016/S0091-6749(99)70471-9
10.1038/nmeth.3337
10.1172/JCI83147
10.1136/thx.43.6.462
10.1093/bioinformatics/bti623
10.1111/j.1365-2249.2007.03451.x
10.1164/rccm.201008-1285OC
10.1371/journal.pone.0006098
10.1186/1465-9921-8-62
10.3109/15412550903499522
10.1186/1471-2172-14-36
10.1164/rccm.201101-0021OC
10.1371/journal.pone.0058556
10.1016/j.jaut.2009.12.003
10.1016/j.jaci.2006.12.640
10.1378/chest.128.4.1995
10.1034/j.1399-3003.2000.01516.x
10.1016/S0954-6111(97)90070-6
10.1371/journal.pone.0107381
10.1183/09031936.00128008
10.1183/09031936.00111707
10.3389/fimmu.2014.00435
10.1136/thx.2004.034009
10.1081/COPD-120028701
10.1378/chest.86.3.383
10.1165/rcmb.2012-0492TR
10.1038/ni.3443
10.1038/nri2343
10.1136/thx.2003.019588
10.1186/s12931-014-0121-2
10.1038/nm1770
ContentType Journal Article
Copyright Copyright American Thoracic Society Apr 2018
Copyright © 2018 by the American Thoracic Society 2018
Copyright_xml – notice: Copyright American Thoracic Society Apr 2018
– notice: Copyright © 2018 by the American Thoracic Society 2018
DBID AAYXX
CITATION
NPM
3V.
7T5
7TM
7TO
7X7
7XB
88A
88E
88I
8AF
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
S0X
7X8
5PM
DOI 10.1165/rcmb.2017-0373OC
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
Biological Science Database
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
SIRS Editorial
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
SIRS Editorial
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
ProQuest Central Student

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1535-4989
EndPage 509
ExternalDocumentID PMC5894501
29206476
10_1165_rcmb_2017_0373OC
Genre Journal Article
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R01 HL124233
– fundername: NHLBI NIH HHS
  grantid: U01 HL089856
– fundername: NHLBI NIH HHS
  grantid: T32 HL007427
– fundername: NHLBI NIH HHS
  grantid: U01 HL089897
– fundername: NHLBI NIH HHS
  grantid: R01 HL126596
GroupedDBID ---
0R~
23M
2WC
53G
5GY
5RE
7X7
88E
88I
8AF
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
AAYXX
ABJNI
ABUWG
ACGFO
ACGFS
ACGOD
ACPRK
ADBBV
AENEX
AFFNX
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BBNVY
BENPR
BES
BHPHI
BPHCQ
BVXVI
C45
CCPQU
CITATION
CS3
DIK
DWQXO
E3Z
EBS
EJD
EMOBN
F5P
FYUFA
GNUQQ
GX1
H13
HCIFZ
HMCUK
HZ~
J5H
LK8
M1P
M2P
M2Q
M5~
M7P
O9-
OBH
OFXIZ
OK1
OVD
OVIDX
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
PZZ
Q2X
RWL
S0X
SJN
TAE
TEORI
THO
TR2
UKHRP
W8F
WOQ
YHG
ZGI
ZXP
ALIPV
NPM
3V.
7T5
7TM
7TO
7XB
88A
8FK
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c312t-caca51a00711bb27cbf82c9c9468964be8654e3ee3828d2e7c51c44d06496cd43
IEDL.DBID 7X7
ISSN 1044-1549
1535-4989
IngestDate Tue Sep 30 17:00:11 EDT 2025
Thu Sep 04 17:01:06 EDT 2025
Fri Jul 25 12:08:12 EDT 2025
Mon Jul 21 05:59:14 EDT 2025
Wed Oct 01 04:08:57 EDT 2025
Thu Apr 24 23:09:37 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords computational biology
immunology
gene expression
chronic obstructive pulmonary disease
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c312t-caca51a00711bb27cbf82c9c9468964be8654e3ee3828d2e7c51c44d06496cd43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
PMID 29206476
PQID 2031266006
PQPubID 2031371
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5894501
proquest_miscellaneous_1973456961
proquest_journals_2031266006
pubmed_primary_29206476
crossref_primary_10_1165_rcmb_2017_0373OC
crossref_citationtrail_10_1165_rcmb_2017_0373OC
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-04-00
2018-Apr
20180401
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle American journal of respiratory cell and molecular biology
PublicationTitleAlternate Am J Respir Cell Mol Biol
PublicationYear 2018
Publisher American Thoracic Society
Publisher_xml – name: American Thoracic Society
References bib14
bib36
bib15
bib37
bib12
bib34
bib13
bib35
bib10
bib32
bib33
bib30
bib31
bib29
bib27
bib28
bib25
bib26
bib23
bib24
bib21
bib22
bib20
bib9
Roberts MEP (bib11) 2015; 2
bib7
bib8
bib5
bib18
bib6
bib19
bib3
bib16
bib4
bib17
bib1
bib2
References_xml – ident: bib24
  doi: 10.1016/j.ygeno.2016.01.004
– ident: bib25
  doi: 10.1164/ajrccm.152.3.7663792
– ident: bib29
  doi: 10.1145/1961189.1961199
– ident: bib26
  doi: 10.1164/rccm.201701-0218PP
– ident: bib9
  doi: 10.4049/jimmunol.0802622
– ident: bib12
  doi: 10.1016/S0091-6749(99)70471-9
– ident: bib21
  doi: 10.1038/nmeth.3337
– ident: bib34
  doi: 10.1172/JCI83147
– ident: bib17
  doi: 10.1136/thx.43.6.462
– ident: bib30
  doi: 10.1093/bioinformatics/bti623
– ident: bib13
  doi: 10.1111/j.1365-2249.2007.03451.x
– ident: bib4
  doi: 10.1164/rccm.201008-1285OC
– ident: bib20
  doi: 10.1371/journal.pone.0006098
– ident: bib14
  doi: 10.1186/1465-9921-8-62
– ident: bib22
  doi: 10.3109/15412550903499522
– ident: bib3
  doi: 10.1186/1471-2172-14-36
– ident: bib27
  doi: 10.1164/rccm.201101-0021OC
– ident: bib15
  doi: 10.1371/journal.pone.0058556
– ident: bib7
  doi: 10.1016/j.jaut.2009.12.003
– ident: bib32
  doi: 10.1016/j.jaci.2006.12.640
– ident: bib5
  doi: 10.1378/chest.128.4.1995
– ident: bib6
  doi: 10.1034/j.1399-3003.2000.01516.x
– ident: bib8
  doi: 10.1016/S0954-6111(97)90070-6
– ident: bib28
  doi: 10.1371/journal.pone.0107381
– ident: bib1
  doi: 10.1183/09031936.00128008
– ident: bib23
  doi: 10.1183/09031936.00111707
– ident: bib36
  doi: 10.3389/fimmu.2014.00435
– ident: bib2
  doi: 10.1136/thx.2004.034009
– ident: bib33
  doi: 10.1081/COPD-120028701
– ident: bib16
  doi: 10.1378/chest.86.3.383
– volume: 2
  start-page: 268
  year: 2015
  ident: bib11
  publication-title: Chronic Obstr Pulm Dis
– ident: bib31
  doi: 10.1165/rcmb.2012-0492TR
– ident: bib10
  doi: 10.1038/ni.3443
– ident: bib37
  doi: 10.1038/nri2343
– ident: bib18
  doi: 10.1136/thx.2003.019588
– ident: bib19
  doi: 10.1186/s12931-014-0121-2
– ident: bib35
  doi: 10.1038/nm1770
SSID ssj0012811
Score 2.4150226
Snippet The progression of chronic obstructive pulmonary disease (COPD) is associated with marked alterations in circulating immune cell populations, but no studies...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 500
SubjectTerms Cell culture
Chronic obstructive pulmonary disease
Gene expression
Hypotheses
Immune response
Immune response (cell-mediated)
Immunity (Disease)
Immunological memory
Innate immunity
Leukocytes (eosinophilic)
Leukocytes (neutrophilic)
Lung diseases
Lymphocytes
Lymphocytes B
Memory cells
Monocytes
Neutrophils
Obstructive lung disease
Original Research
Population studies
Respiratory function
Singers
Smoking
Studies
Systematic review
Title Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression
URI https://www.ncbi.nlm.nih.gov/pubmed/29206476
https://www.proquest.com/docview/2031266006
https://www.proquest.com/docview/1973456961
https://pubmed.ncbi.nlm.nih.gov/PMC5894501
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1535-4989
  dateEnd: 20241003
  omitProxy: true
  ssIdentifier: ssj0012811
  issn: 1044-1549
  databaseCode: DIK
  dateStart: 19970701
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1535-4989
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0012811
  issn: 1044-1549
  databaseCode: GX1
  dateStart: 19970701
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1535-4989
  dateEnd: 20190930
  omitProxy: true
  ssIdentifier: ssj0012811
  issn: 1044-1549
  databaseCode: 7X7
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1535-4989
  dateEnd: 20190930
  omitProxy: true
  ssIdentifier: ssj0012811
  issn: 1044-1549
  databaseCode: BENPR
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1535-4989
  dateEnd: 20250103
  omitProxy: true
  ssIdentifier: ssj0012811
  issn: 1044-1549
  databaseCode: BENPR
  dateStart: 19940101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELaglRAXBC2PhVIZCSFxsLpObCc-oaUPdUFtV5RKe4tsZyJWarNLd3vYX8LfZSZxAgtSj5EfSfyN7RnP-BvG3g8Tr2lxFMaAFQqGILwDL6SuvHPBgm0o88_OzemV-jLV03jgtoxhld2a2CzU5TzQGTka6anEzQSF5NPip6CsUeRdjSk0HrJtiaoKSXU27Q0uchLJzjVp9MFtuPEUzJWJYZqlF4ebW9F_-uW_YZJ_7TsnT9mTqDDyUYvwM_YA6h22O6rRWL5Z8w-8CeFszsZ32KOz6CnfZb9aKvJZ4HQbB3U8Pq_4qHQLWt64q0s-rrEP4OPmgshqjW8A3oEFJacDWh6pc_mFjzyz2HZyd41j4W7X_Kh17vBLwPlAXVC3l4sZMSAQ8X9fYUJBYC0ByHN2dXL8_fBUxCQMIuCAr0RwwWnpSBWR3idZ8FWeBBusMrk1ykNutIIUIEXbrUwgC1oGpUpUdawJpUpfsK16XsMrxhEQqHQIJsfWlUlycMqrtNQ-5CFzasAOOjyKEBnKKVHGddFYKkYXhGBBCBYtggP2sW-xaNk57qm710FcxHm6LP5I1YC964txhpHbxNUwv1sW0mYpqpnWyAF72UpE_zLK9WVUhq2zDVnpKxB792ZJPfvRsHjr3Co9lK_v_6w37DH-Q97GCu2xLQQb3qIatPL7jazvs-3Px-eTb_h0NP76GyKXD4U
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXBC2PhQJGAiQOUfOwneSA0Kql2qXdtlJbaW-p7UzESm126W6F9pfwL_iNzOQFC1JvPcceJ5nxPDzjbwDe-aFVrBw9rTH1JProWYPWC1RhjXEpphVk_uhQD87k17Ear8Gv9i4Ml1W2OrFS1PnU8Rk5BelRQMaEhOTz7LvHXaM4u9q20KjFYh-XPyhkm38a7hJ_34fh3pfTnYHXdBXwHFFYeM44owLDtjWwNoydLZLQpS6VOkm1tJhoJTFCjCgYyUOMnQqclDnZ7lS7XEZE9w7clZEvGas_HncBHielgjYVqtX2lbu0XDwWe34UR0c7q6bvP3_237LMv-zc3iN42Diool9L1GNYw3IDNvslBeeXS_FBVCWj1Vn8BtwbNZn5TfhZQ59PnODbP-RTimkh-rmZsToVpszFsCQaKIbVhZTFklZA0QoH5oIPhEUD1SuObINrS3OPry_o35urpditk0niBGn_MQkmezKbMOICNxroBhxz0VkNOPIEzm6FPU9hvZyW-BwEMQQL5ZxOaHahwwSNtDLKlXWJi43swXbLj8w1iOjcmOMiqyIjrTLmYMYczGoO9uBjN2NWo4HcMHarZXHW6IV59keKe_C2e0w7mtM0psTp9TwL0jgitzbVQQ-e1RLRLca9xbSMaXa8IivdAEYLX31STr5VqOEqSaXygxc3v9YbuD84HR1kB8PD_ZfwgL4nqeuUtmCdGI-vyAVb2NeV3As4v-2N9hsYfUmS
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Systemic+Markers+of+Adaptive+and+Innate+Immunity+Are+Associated+with+Chronic+Obstructive+Pulmonary+Disease+Severity+and+Spirometric+Disease+Progression&rft.jtitle=American+journal+of+respiratory+cell+and+molecular+biology&rft.au=Halper-Stromberg%2C+Eitan&rft.au=Yun%2C+Jeong+H&rft.au=Parker%2C+Margaret+M&rft.au=Singer%2C+Ruth+Tal&rft.date=2018-04-01&rft.eissn=1535-4989&rft.volume=58&rft.issue=4&rft.spage=500&rft_id=info:doi/10.1165%2Frcmb.2017-0373OC&rft_id=info%3Apmid%2F29206476&rft.externalDocID=29206476
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1044-1549&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1044-1549&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1044-1549&client=summon